Congratulations to FluoretiQ Limited

FluoretiQ competed against more than 210 startups, scaleups, and SMEs from across the globe, presenting at the Grand Finale in Hong Kong before an international jury including representatives from the University of Cambridge, EY, Santander Bank, and the Hong Kong Science and Technology Parks Corporation.

FluoretiQ is developing rapid point-of-care diagnostics for bacterial infections in veterinary medicine. Its VERI-5® Vet platform uses proprietary Veri-5® technology to identify the most common canine and feline urinary tract infection (UTI) pathogens directly from urine in around 15 minutes at the point of care. No send-away. No days of waiting. The answer while the patient is still in the room.

Commenting on the award, Dr. Neciah Dorh, CEO & Co-Founder, FluoretiQ Limited, said:

"The Hong Kong MedTech Innovation World Cup® win is a major boost for us, and positions FluoretiQ as a leading voice in global MedTech innovation with a mission grounded firmly in improving outcomes for animals, their owners, and the veterinary professionals who care for them. We are especially honoured to receive this award at the first MedTech Innovation World Cup to be hosted in Hong Kong in 10 years."

Wendy Furness, Co-Founder of Animal Health Angels, added:

We are delighted for Neciah and the FluroretiQ team. The work that they are doing offers real-world improvements in diagnostics as well as combating the AMR threat. Congratulations from all of us -very well deserved.

This recognition highlights the growing importance of innovation in veterinary diagnostics and marks an exciting milestone for the FluoretiQ team.

Congratulations to everyone involved.